Therefore, further investigation into the synergistic effects of PRKCI inhibition is warranted, but overall these data suggest that PRKCI is an attractive molecular target with enhanced specificity to ovarian cancer signaling. The gene discussed is PRKCI; the disease is ovarian cancer.